EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanoformulated Terpenoids in Cancer: A Review of Therapeutic Applications, Mechanisms, and Challenges

Arunagiri Sharmila iD, Priyanka Bhadra, Chandra Kishore iD, Chinnadurai Immanuel Selvaraj iD, Joachim Kavalakatt iD, Anupam Bishayee iD

Cancers · 16.09.2025 · 17 (18) · 3013

DOI: 10.3390/cancers17183013 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 16.09.2025. Verfasst von Arunagiri Sharmila und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, School of Biosciences and Technology, Vellore Institute of Technology, Vellore 632 014, Tamil Nadu, India. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 207 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer remains a major global health concern, and thus, there is a growing demand for efficient and selective therapies with low systemic toxicity. Natural bioactive compounds have emerged as promising alternatives, and terpenoids have shown notable anticancer properties. They exert antiproliferative, proapoptotic, anti-invasive, and antimetastatic effects through the regulation of multiple molecular targets and signaling pathways, including modulation of apoptosis, suppression of angiogenesis, and inhibition of tumor-promoting inflammation. However, their clinical translation is constrained by poor aqueous solubility, low bioavailability, rapid systemic clearance, and inadequate tumor accumulation. Recent advances in nanotechnology offer strategies to overcome these limitations. Nanocarrier-based systems improve the solubility, stability, and pharmacokinetics of terpenoids, while enabling tumor-targeted delivery and controlled release. Various strategies, such as enhanced permeability and retention effect, ligand-mediated active targeting, and stimuli-responsive release have been used to achieve selective tumor accumulation and improved therapeutic outcomes. The purpose of this review is to provide a comprehensive evaluation of nanoformulated terpenoids in cancer with a special emphasis on their therapeutic applications and mechanisms of action. Preclinical studies demonstrate that nanocarrier-loaded terpenoids significantly increase bioavailability, enhance apoptosis, and suppress tumor angiogenesis compared with free terpenoids. The incorporation of artificial intelligence and machine learning further holds promise for the rational design of nanomedicines, accelerating their path toward clinical translation. Collectively, these developments position nanoformulated terpenoids as a powerful platform in precision oncology with strong potential for future application in cancer therapy.

Schlagwörter

Stichwörter der Autor:innen

anticancer effectsdrug deliverymolecular mechanismsnanoformulationsterpenoids

Autor:innen und Institutionen

  • Department of Biotechnology, School of Biosciences and Technology, Vellore Institute of Technology, Vellore 632 014, Tamil Nadu, India.
  • Department of Biological Sciences, Bose Institute, Kolkata 700 091, West Bengal, India.
  • Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Department of Genetics and Plant Breeding, VIT School of Agricultural Innovations and Advanced Learning, Vellore Institute of Technology, Vellore 632 014, Tamil Nadu, India.
  • Department of Pharmacology, College of Osteopathic Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, FL 34211, USA.

ORCID-Profile: Arunagiri Sharmila, Chandra Kishore, Chinnadurai Immanuel Selvaraj, Joachim Kavalakatt, Anupam Bishayee

Zitieren

APA

Sharmila, A., Bhadra, P., Kishore, C., Selvaraj, C. I., Kavalakatt, J., & Bishayee, A. (2025). Nanoformulated Terpenoids in Cancer: A Review of Therapeutic Applications, Mechanisms, and Challenges. Cancers, 17(18), 3013. https://doi.org/10.3390/cancers17183013

Vancouver

Sharmila A, Bhadra P, Kishore C, Selvaraj CI, Kavalakatt J, Bishayee A. Nanoformulated Terpenoids in Cancer: A Review of Therapeutic Applications, Mechanisms, and Challenges. Cancers. 2025;17(18):3013. doi:10.3390/cancers17183013

BibTeX
@article{Sharmila2025,
  author = {Sharmila, Arunagiri and Bhadra, Priyanka and Kishore, Chandra and Selvaraj, Chinnadurai Immanuel and Kavalakatt, Joachim and Bishayee, Anupam},
  title = {Nanoformulated Terpenoids in Cancer: A Review of Therapeutic Applications, Mechanisms, and Challenges},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {18},
  pages = {3013},
  doi = {10.3390/cancers17183013}
}
Kostenlos starten →